Current Affairs
Here is Zimbabwe’s Breakthrough in HIV Prevention with Lenacapavir Rollout

Zimbabwe is making history as one of only ten countries worldwide selected to roll out lenacapavir, a revolutionary twice-yearly HIV prevention medicine.
Announced by the U.S. Embassy in Harare, this groundbreaking initiative, in partnership with Gilead Sciences and the Global Fund, marks a pivotal moment in the global fight against HIV/AIDS.
With a clinical trial success rate exceeding 99%, lenacapavir offers hope for millions and positions Zimbabwe as a leader in ending new HIV infections.
A New Era in HIV Prevention: Lenacapavir’s Global Impact
Lenacapavir, developed by U.S.-based Gilead Sciences, is the world’s first twice-yearly injectable HIV prevention medicine.
Unlike daily oral medications, this long-acting treatment offers a convenient and highly effective solution to prevent HIV infection.
In large-scale clinical trials, over 99% of participants using lenacapavir remained HIV-negative, showcasing its potential to transform HIV prevention strategies worldwide.
For Zimbabwe, being selected as one of the first countries to roll out this medicine is a testament to its commitment to combating the HIV epidemic.
Why Zimbabwe’s Selection Matters
Zimbabwe has been a frontline fighter in the battle against HIV/AIDS for decades. With a population heavily impacted by the epidemic, the introduction of lenacapavir represents a game-changer.
The U.S. Embassy in Harare, in collaboration with Gilead Sciences and the Global Fund, is spearheading this initiative to ensure that Zimbabweans, particularly vulnerable groups like pregnant and breastfeeding women, gain access to this life-saving medicine.
This rollout not only aims to reduce new infections but also strengthens Zimbabwe’s healthcare infrastructure, paving the way for a healthier future.
Key Benefits of Lenacapavir in Zimbabwe
The lenacapavir rollout in Zimbabwe is more than just a medical advancement—it’s a holistic approach to public health. Here are the key benefits:
– Protecting Future Generations: By prioritising pregnant and breastfeeding women, lenacapavir helps prevent mother-to-child HIV transmission, safeguarding Zimbabwe’s next generation.
– Strengthening Healthcare Systems: The partnership with the Global Fund and Gilead Sciences empowers Zimbabwe’s healthcare systems to deliver innovative treatments effectively.
– Affordability and Accessibility: Efforts are underway to make lenacapavir affordable and widely available, ensuring no one is left behind in the fight against HIV.
– High Efficacy: With a 99% success rate in preventing HIV, lenacapavir offers unmatched protection compared to existing prevention methods.
A Global Partnership for a Healthier Future
The success of this initiative is rooted in international collaboration. The U.S. Embassy Harare, through its partnership with Gilead Sciences and the Global Fund, exemplifies American leadership in global health innovation.
This collaboration not only brings cutting-edge medicine to Zimbabwe but also sets a model for other nations.
By combining resources, expertise, and commitment, this partnership is driving progress toward a world free of new HIV infections.
How Lenacapavir Works
Lenacapavir is a long-acting injectable administered every six months, making it a convenient alternative to daily HIV prevention pills.
It works by inhibiting the HIV at multiple stages of its lifecycle, offering robust protection against infection.
This breakthrough is particularly significant for high-risk groups, such as young women and key populations in Zimbabwe, where HIV prevalence remains a challenge. The twice-yearly dosing schedule reduces the burden of adherence, making it easier for individuals to stay protected.
The Broader Impact on Zimbabwe’s Fight Against HIV
Zimbabwe’s selection for the lenacapavir rollout is a major step toward achieving the global goal of ending HIV as a public health threat by 2030. By focusing on prevention, this initiative complements existing efforts like antiretroviral therapy (ART) and community-based HIV education programs.
Furthermore, it empowers Zimbabwe to lead its own response to the epidemic, fostering resilience and self-reliance in its healthcare system.
A Vision for a Healthier Zimbabwe
The introduction of lenacapavir is more than a medical milestone—it’s a vision for a safer, stronger, and healthier Zimbabwe.
By reducing new HIV infections, protecting vulnerable populations, and strengthening healthcare systems, this initiative lays the foundation for a future where communities thrive free from the burden of HIV/AIDS.
The U.S. Embassy in Harare’s commitment to this cause reflects a shared global vision of health equity and innovation.
How Zimbabwe’s Success Can Inspire the World
Zimbabwe’s role in the lenacapavir rollout serves as an inspiration for other nations battling HIV/AIDS.
The country’s proactive approach, supported by international partners, demonstrates how innovation, collaboration, and accessibility can transform public health outcomes. As Zimbabwe leads the way, it sets a precedent for other countries to adopt similar strategies, bringing the world closer to ending the HIV epidemic.
Zimbabwe’s selection as one of the first countries to roll out lenacapavir is a historic milestone in the global fight against HIV.
With a 99% efficacy rate, this twice-yearly injectable medicine has the potential to save millions of lives and reshape the future of HIV prevention.
Through partnerships with the U.S. Embassy in Harare, Gilead Sciences, and the Global Fund, Zimbabwe is not only protecting its citizens but also leading the charge toward a world without new HIV infections.
This initiative is a powerful reminder that with innovation, collaboration, and commitment, we are not just fighting HIV—we are winning.
Current Affairs
Chamisa Leaves Flock Behind

Former Zimbabwean opposition leader turned social media activist Nelson Chamisa has enrolled for a two-year doctoral programme at the University of Oxford, sources close to him have confirmed.
The development comes months after Chamisa announced his withdrawal from frontline politics, leaving many of his supporters uncertain about the future of the Citizens Coalition for Change (CCC), the party he founded in 2022.
A close associate told Hurumende News Hub that Chamisa’s decision to pursue studies abroad signals “a new chapter” in his life, while deepening questions about his long-term role in Zimbabwean politics.
“Chamisa has left his followers behind to focus on a PhD at Oxford. He believes this is the right time to reflect, retool, and prepare for new opportunities,” the source said.
Chamisa, once considered the face of opposition politics in Zimbabwe, shocked many in January 2024 when he announced he was stepping down as CCC leader, citing infiltration and lack of accountability within the movement.
Since then, he has maintained an active presence on social media, but his formal political activities have been minimal.
Chamisa, a lawyer and pastor by training, rose to prominence as a youthful protégé of the late MDC leader Morgan Tsvangirai.
He narrowly lost the disputed 2018 presidential election to President Emmerson Mnangagwa and has remained a polarising figure in Zimbabwean politics ever since.
His decision to leave the political stage has left many of his followers without clear leadership, with internal divisions continuing to fracture the opposition movement.
This Oxford enrollment could mark a permanent exit from active politics, while others believe he may return with renewed strategy and international clout.
For now, Chamisa’s political future remains uncertain, but his academic pursuit in the United Kingdom signals a definitive shift away from the turbulent terrain of Zimbabwe’s opposition politics.
Current Affairs
Nyamupinga: Prison Alone Not Enough, Castrate Rapists

A female legislator has sparked debate in Parliament after proposing the castration of convicted r@pists, especially repeat offenders, as a way to curb rising cases of s@xual violence.
Goromonzi West Member of Parliament, Beata Nyamupinga, raised the issue during Tuesday’s National Assembly sitting, urging lawmakers to urgently introduce tougher measures to safeguard women and children.
Her appeal came in the wake of two disturbing cases that drew widespread outrage the r@pe of a Grade 7 girl by a tout at Harare’s Rezende bus terminus, and a viral video showing two teenage boys allegedly gang-r@ping a 17-year-old girl.
“We are crying over the issue of rape. We are grieving as women of this country. The whole nation is not happy to see a grown man having s@xual intercourse with a young child,” Nyamupinga told Parliament.
She further encouraged her female colleagues to lobby President Emmerson Mnangagwa directly, stressing that traditional prison sentences were not enough since many offenders re-offend after release.
“Can we have something as a matter of urgency to ensure that if somebody is caught having s@xual intercourse with a minor, they should be castrated. If he maintains that manhood, he will not have the discipline to stop,” she argued.
Nyamupinga’s remarks received applause across the House, with many MPs acknowledging the seriousness of the issue.
Acting Speaker Joseph Tshuma condemned the abuse of minors as “incomprehensible and appalling” and advised Nyamupinga to introduce a Private Members’ Bill to push for tougher penalties, including possible life imprisonment for child r@pists.
“While Zimbabwe has abolished the death penalty, certain crimes, particularly the rape of minors, demand severe consequences,” Tshuma said.
Current Affairs
Masunda Fingered as Mastermind in NetOne CEO Fraud Storm

NetOne CEO Raphael Mushanawani is under arrest over US$1.2 million fraud allegations, but his lawyers say it is a “political hit job,” with Learnmore Masunda as the mastermind behind the arrest.
In a strongly worded letter to the Zimbabwe Anti-Corruption Commission (ZACC), Mushanawani’s lawyer, Admire Rubaya, dismissed the charges as fabricated.
“Our client is a victim in a well-orchestrated ploy to extirpate him from the helm of NetOne,” Rubaya wrote, adding that the accusations were linked to internal power struggles.
He claimed that some individuals eyeing Mushanawani’s position had “name-dropped very powerful individuals” but stressed that “there is no involvement of any such political figures.”
ZACC alleges Mushanawani engaged Lunartech Solutions (Pvt) Ltd to upgrade NetOne’s SAGE 1000 system without board approval, despite the company already having a US$3.5 million contract with Farevic Systems (Pvt) Ltd for a new Enterprise Resource Planning (ERP) system.
But the defense insists the upgrade was necessary and board-approved.
“An upgrade to SAGE L200 was imperative and a viable alternative to ensure continued operations and avoid hacking risks,” the lawyers argued, saying the two systems needed to run concurrently until the ERP was fully functional.
They further argued that the SAGE upgrade was part of NetOne’s 2025 Strategic Plan to modernise its technology infrastructure.
The lawyers also rejected ZACC’s claim that Mushanawani authorised fraudulent addendums worth US$1.2 million.
“The only payments made are US$184,800 and US$88,002.57,” the letter stated.
On the allegation that Mushanawani approved an unapproved US$79,467 consultancy deal with Diztech (Pvt) Ltd, the defense was equally dismissive.
“No contract was ever signed and not a dime has been paid,” the lawyers responded.
Concluding their defense, Mushanawani’s legal team said he was being unfairly targeted.
“Our client is being victimised for doing things right and acting in the best interests of his principal. ZACC must disregard the machinations of his detractors,” Rubaya added.
-
Crime and Courts3 days ago
Masasi High School Abuse Scandal Sparks Public Outcry
-
Crime and Courts6 days ago
Kuwadzana Man Jailed for Reckless Driving and Driving Without a Licence
-
Current Affairs2 months ago
Breaking: ZIMSEC June 2025 Exam Results Now Available Online
-
Current Affairs1 month ago
Munhumutapa Day: Zimbabwe’s Newest Public Holiday Set for Annual Observance
-
Current Affairs4 weeks ago
Government Bans Tinted Car Windows in Nationwide Crime Crackdown
-
Current Affairs5 days ago
Vehicle Emissions on the Rise in Harare, A Growing Concern
-
Current Affairs2 weeks ago
Exposed: Harare GynecologistChirume Accused of Negligence, Extortion, and Abuse
-
Current Affairs2 months ago
No VP Change: Government Rejects Mutinhiri Appointment Rumours
Pingback: President Mnangagwa Appeals for Patriotism, Progress – Hurumende